Information  X 
Enter a valid email address

Alumasc Group Plc (ALU)

  Print      Mail a friend       Annual reports

Thursday 24 May, 2018

Alumasc Group Plc

Director/PDMR Shareholding

RNS Number : 2334P
Alumasc Group PLC
24 May 2018
 

 

 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them

 

 

1.         

Details of the person discharging managerial responsibilities / person closely associated

a.         

Name

Claire Armfield

 

2.         

Reason for the notification

a.         

Position/status

Person Closely Associated to David Armfield, Non-Executive Director

 

b.         

Initial notification

/Amendment

 

Initial notification

 

3.         

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.         

Name

The Alumasc Group plc

 

b.         

LEI

2138002MV11VKZFJ4359

 

4.         

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.         

Description of the

Financial instrument, type

of instrument

Identification code

 

 

Ordinary 12.5p shares

 

 

GB0000280353

b.         

Nature of the transaction

Purchase of shares

c.         

Price(s) and volume(s)

 

Price(s)

 

Volume(s)

135.0p

14,400

 

 

d.         

Aggregated information

·      Aggregated volume

·      Price

 

 

14,400 Ordinary 12.5p shares (purchased) -  135.0 pence per share

 

e.         

Date of the transaction

2018-05-22

 

f.         

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHSEEFDLFASEII

a d v e r t i s e m e n t